68 related articles for article (PubMed ID: 32214110)
1. Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9.
Lan YY; Hsiao JR; Chang KC; Chang JS; Chen CW; Lai HC; Wu SY; Yeh TH; Chang FH; Lin WH; Su IJ; Chang Y
J Virol; 2012 Jun; 86(12):6656-67. PubMed ID: 22514348
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) Enhances ATP Production in B Cell Tumors through mTOR and HIF-1α.
Incrocci R; Monroy Del Toro R; Devitt G; Salimian M; Braich K; Swanson-Mungerson M
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612754
[TBL] [Abstract][Full Text] [Related]
3. Role of Peroxiredoxin 1 Induced by Epstein-Barr Virus Infection in Nasopharyngeal Carcinoma.
Noh MH; Kim HY; Kim DH; Moon SH; Hur DY
Anticancer Res; 2024 Apr; 44(4):1425-1440. PubMed ID: 38537989
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis.
Pegtel DM; Subramanian A; Sheen TS; Tsai CH; Golub TR; Thorley-Lawson DA
J Virol; 2005 Dec; 79(24):15430-42. PubMed ID: 16306614
[TBL] [Abstract][Full Text] [Related]
5. The Epstein-Barr virus-encoded LMP2A and LMP2B proteins promote epithelial cell spreading and motility.
Allen MD; Young LS; Dawson CW
J Virol; 2005 Feb; 79(3):1789-802. PubMed ID: 15650203
[TBL] [Abstract][Full Text] [Related]
6. Chronic HIV-1 Tat action induces HLA-DR downregulation in B cells: A mechanism for lymphoma immune escape in people living with HIV.
Shmakova A; Hugot C; Kozhevnikova Y; Schwager Karpukhina A; Tsimailo I; Gérard L; Boutboul D; Oksenhendler E; Szewczyk-Roszczenko O; Roszczenko P; Buzun K; Sheval EV; Germini D; Vassetzky Y
J Med Virol; 2024 Feb; 96(2):e29423. PubMed ID: 38285479
[TBL] [Abstract][Full Text] [Related]
7. Study on the regulatory mechanism of latent membrane protein 2A on GCNT3 expression in nasopharyngeal carcinoma.
Chen Y; Zhang Y; Duo S; Liu W; Luo B
Virus Genes; 2024 May; ():. PubMed ID: 38739247
[TBL] [Abstract][Full Text] [Related]
8. CHMP2A regulates broad immune cell-mediated antitumor activity in an immunocompetent in vivo head and neck squamous cell carcinoma model.
Yun J; Saddawi-Konefka R; Goldenson B; Al-Msari R; Bernareggi D; Thangaraj JL; Tang S; Patel SH; Luna SM; Gutkind JS; Kaufman D
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38702144
[TBL] [Abstract][Full Text] [Related]
9. The Role of Natural Killer Cells in the Tumor Immune Microenvironment of EBV-Associated Nasopharyngeal Carcinoma.
Li S; Dai W; Kam NW; Zhang J; Lee VHF; Ren X; Kwong DL
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610990
[TBL] [Abstract][Full Text] [Related]
10. Update on Radiotherapy Changes of Nasopharyngeal Carcinoma Tumor Microenvironment.
Zhu DQ; Su C; Li JJ; Li AW; Luv Y; Fan Q
World J Oncol; 2023 Oct; 14(5):350-357. PubMed ID: 37869238
[TBL] [Abstract][Full Text] [Related]
11. The Role of NK Cells in EBV Infection and Related Diseases: Current Understanding and Hints for Novel Therapies.
Desimio MG; Covino DA; Rivalta B; Cancrini C; Doria M
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980798
[TBL] [Abstract][Full Text] [Related]
12. Role of Exosomes and Their Potential as Biomarkers in Epstein-Barr Virus-Associated Gastric Cancer.
Kim B; Kim KM
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672418
[TBL] [Abstract][Full Text] [Related]
13. Revealing the crosstalk between nasopharyngeal carcinoma and immune cells in the tumor microenvironment.
Jiang J; Ying H
J Exp Clin Cancer Res; 2022 Aug; 41(1):244. PubMed ID: 35964134
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Reprogramming and Immune Evasion in Nasopharyngeal Carcinoma.
Huang H; Li S; Tang Q; Zhu G
Front Immunol; 2021; 12():680955. PubMed ID: 34566954
[TBL] [Abstract][Full Text] [Related]
15. EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes.
Su C; Lu F; Soldan SS; Lamontagne RJ; Tang HY; Napoletani G; Farrell PJ; Tempera I; Kossenkov AV; Lieberman PM
PLoS Pathog; 2021 Aug; 17(8):e1009834. PubMed ID: 34352044
[TBL] [Abstract][Full Text] [Related]
16. The Role of Immunogenetics in COVID-19.
Pojero F; Candore G; Caruso C; Di Bona D; Groneberg DA; Ligotti ME; Accardi G; Aiello A
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807915
[TBL] [Abstract][Full Text] [Related]
17. The Role of NK Cells in EBV Infection and EBV-Associated NPC.
Png YT; Yang AZY; Lee MY; Chua MJM; Lim CM
Viruses; 2021 Feb; 13(2):. PubMed ID: 33671917
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma.
Viet NH; Trung NQ; Dong LT; Trung LQ; Espinoza JL
J Cancer Res Clin Oncol; 2021 Mar; 147(3):713-723. PubMed ID: 33392659
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of HLA-ABC expression through promoter hypermethylation and downmodulation of MIC-A/B surface expression in LMP2A-positive epithelial carcinoma cell lines.
Singh S; Banerjee S
Sci Rep; 2020 Mar; 10(1):5415. PubMed ID: 32214110
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
